Donation

title card for Dr. Rajkumar's interview at ASCO 2019

Outcomes of patients with t(11;14) multiple myeloma: An international myeloma working group (IMWG) multicenter study

June 4, 2019
ASCO/EHA
title card for Updated Risk Stratification Model for SMM

Updated risk stratification model for smoldering multiple myeloma (SMM) incorporating the revised IMWG diagnostic criteria

June 2, 2019
ASCO/EHA
Ask Dr Durie MRD Remission

If the MRD test is negative, is that always a good predictor of a longer remission?

May 23, 2019
Ask Dr. Durie
Ask Dr Durie: Are there medical issues linked to MGUS other than developing multiple myeloma? text overlaid on image of Dr. Durie

Are there medical issues linked to MGUS other than developing multiple myeloma?

May 9, 2019
Ask Dr. Durie
Living Well teleconference banner and Dr. Durie's picture.

Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly Diagnosed

April 25, 2019
Living Well with Myeloma
Ask Dr Durie in front of a chalk board

What imaging studies, or scans, should myeloma patients undergo?

April 18, 2019
Ask Dr. Durie
Ask Dr. Durie in front of chalk board

Why is 17p deletion (17p-) considered to be a poor prognostic factor for myeloma patients?

April 4, 2019
Ask Dr. Durie
Dr. Durie in front of a chalk board

What is CRISPR technology and has there been an interest for it in the United States?

March 21, 2019
Ask Dr. Durie
Slide on Genetic Mutation

How can myeloma patients achieve a cure if myeloma is caused by genetic mutations?

March 14, 2019
Ask Dr. Durie
Slide about MGUS and kidney damage

Is there a link between MGUS and kidney damage in myeloma patients?

March 7, 2019
Ask Dr. Durie
Role of Crispr

How CRISPR Could Impact the Future of Myeloma Treatment

March 5, 2019
Emerging Therapies
Dr. Durie in front of a chalk board

Is the combination of Velcade, Revlimid, and dexamethasone (VRd) helpful for myeloma patients over the age of 65?

February 14, 2019
Ask Dr. Durie

Give Where Most Needed

Learn More